These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Development and application of a double-antigen sandwich enzyme-linked immunosorbent assay for detection of antibodies to porcine circovirus 2. Ge M, Luo W, Jiang D, Li R, Zhao W, Chen G, Yang X, Yu X. Clin Vaccine Immunol; 2012 Sep; 19(9):1480-6. PubMed ID: 22815145 [Abstract] [Full Text] [Related]
7. Establishment of a Rep' protein antibody detection method to distinguish natural infection with PCV2 from subunit vaccine immunization. Chen Q, Rong J, Li G, Xu B, Wang X, Hu J, Rong M, Li H. J Med Microbiol; 2020 Sep; 69(9):1183-1196. PubMed ID: 32812860 [Abstract] [Full Text] [Related]
8. A nanobody-horseradish peroxidase fusion protein-based competitive ELISA for rapid detection of antibodies against porcine circovirus type 2. Mu Y, Jia C, Zheng X, Zhu H, Zhang X, Xu H, Liu B, Zhao Q, Zhou EM. J Nanobiotechnology; 2021 Feb 01; 19(1):34. PubMed ID: 33526021 [Abstract] [Full Text] [Related]
10. Establishment and application of a competitive enzyme-linked immunosorbent assay differentiating PCV2 antibodies from mixture of PCV1/PCV2 antibodies in pig sera. Han S, Xiao Y, Zheng D, Gu Y, Xuan Y, Jin Y, Pang W, Huang Y, Li X, Deng J, Tian K. BMC Vet Res; 2016 Aug 26; 12(1):175. PubMed ID: 27561335 [Abstract] [Full Text] [Related]
13. Immunogenicity Evaluation of Modified Adenovirus Vaccines Expressing Porcine Circovirus Type 2 Capsid Protein in Pigs. Li D, Xu D, Wang Z, Du Q, Chang L, Zhao X, Huang Y, Tong D. Viral Immunol; 2017 Mar 26; 30(2):111-119. PubMed ID: 27996636 [Abstract] [Full Text] [Related]
14. A novel strategy for an anti-idiotype vaccine: nanobody mimicking neutralization epitope of porcine circovirus type 2. Deng Y, Sheng Y, Zhang G, Sun Y, Wang L, Ji P, Zhu J, Wang G, Liu B, Zhou E-M, Cai X, Tu Y, Hiscox JA, Stewart JP, Mu Y, Zhao Q. J Virol; 2024 Feb 20; 98(2):e0165023. PubMed ID: 38271227 [Abstract] [Full Text] [Related]
15. Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines. Zanotti C, Martinelli N, Lelli D, Amadori M. Viral Immunol; 2015 Dec 20; 28(10):600-8. PubMed ID: 26401584 [Abstract] [Full Text] [Related]
16. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice. Wang Y, Lu Y, Liu D, Wei Y, Guo L, Wu H, Huang L, Liu J, Liu C. Appl Microbiol Biotechnol; 2015 Feb 20; 99(3):1155-63. PubMed ID: 25487886 [Abstract] [Full Text] [Related]
17. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development. Zhang C, He F, Li N, Du W, Wen J, Wu X, Shi J, Li C, Liu C, Xu S, Han H, Hrabchenko N, Han X, Li J. Microb Pathog; 2024 May 20; 190():106630. PubMed ID: 38556102 [Abstract] [Full Text] [Related]
19. Generation of E. coli-derived virus-like particles of porcine circovirus type 2 and their use in an indirect IgG enzyme-linked immunosorbent assay. Zhang Y, Wang Z, Zhan Y, Gong Q, Yu W, Deng Z, Wang A, Yang Y, Wang N. Arch Virol; 2016 Jun 20; 161(6):1485-91. PubMed ID: 26973229 [Abstract] [Full Text] [Related]
20. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Wu PC, Lin WL, Wu CM, Chi JN, Chien MS, Huang C. Appl Microbiol Biotechnol; 2012 Sep 20; 95(6):1501-7. PubMed ID: 22526782 [Abstract] [Full Text] [Related] Page: [Next] [New Search]